Author:
Kushwah Bhoopendra Singh,Padhy Hara Prasad,Khemchandani Rahul,Golla Vijaya Madhyanapu,Kanchupalli Vinay Kumar,Sonti Rajesh,Samanthula Gananadhamu
Funder
National Institute of Pharmaceutical Education and Research, Ahmedabad
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference21 articles.
1. 〈https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/210259s000lbl.pdf〉 (Accessed 27 May , 2022).
2. Acalabrutinib: first global approval;Markham;Drugs,2018
3. Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor;Wu;J. Hematol. Oncol.,2016
4. Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia;Byrd;N. Engl. J. Med.,2016
5. Stability Testing;Q1B;Photo Test. N. Drug Subst. Prod.,1996
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献